Stem cell research survey initiated by ddn and Mizuho
The survey contains about a dozen questions and takes less than five minutes to complete
Concurrent with our summer feature series on stem cell research, Drug Discovery News (ddn), in partnership with the healthcare research team at investment bankMizuho Securities USA, is conducting a reader survey on current stemcell trends and usage.
Whether you work at the bench or for anacademic institution—or anywhere in between—we are interested in finding out about your participation in and views on the stem cell market.
The survey contains 20 questions and takes four to fiveminutes to complete. To participate, please click on the link below:
http://www.surveymonkey.com/s/9HVX6V2
All information will remain confidential, and only aggregate results will be published.
If you are interested in receiving a copy of the survey results, please indicate at the end of the survey.
Whether you work at the bench or for anacademic institution—or anywhere in between—we are interested in finding out about your participation in and views on the stem cell market.
The survey contains 20 questions and takes four to fiveminutes to complete. To participate, please click on the link below:
http://www.surveymonkey.com/s/9HVX6V2
All information will remain confidential, and only aggregate results will be published.
If you are interested in receiving a copy of the survey results, please indicate at the end of the survey.
